Avalon Pharma secures SAR 30M loan from SIDF

26/02/2025 Argaam

Content Summary:

Loading data...
Positive: 0%
Neutral: 0%
Negative: 0%

Comments Analysis:

Positive: 0%
Neutral: 0%
Negative: 0%
Comments Summary:Loading data...
Please note that chart summaries are generated by AI, thorough review of the charts is advised for detailed comprehension.
Logo ofMiddle East Pharmaceutical Industries Co. (Avalon Pharma)

Logo of Middle East Pharmaceutical Industries Co. (Avalon Pharma) 

Middle East Pharmaceutical Industries Co. (Avalon Pharma) signed on Feb. 25 a long-term financing loan agreement with the Saudi Industrial Development Fund (SIDF) for SAR 30 million. 
 
In a statement to Tadawul, the company said that the financing period is seven Hijri years, noting that the loan will be repaid in 12 equal semi-annual installments according to the repayment schedule agreed upon with the fund.
 

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.